Van Cleef Asset Management Inc Has $2.37 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Van Cleef Asset Management Inc decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,531 shares of the healthcare conglomerate's stock after selling 972 shares during the period. Van Cleef Asset Management Inc's holdings in UnitedHealth Group were worth $2,373,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. Geode Capital Management LLC boosted its stake in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors grew its holdings in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $6,375,744,000. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. increased its holdings in shares of UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.4%

Shares of UNH stock traded up $4.30 during trading on Friday, reaching $303.81. The company's stock had a trading volume of 9,789,082 shares, compared to its average volume of 7,670,774. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The business has a fifty day moving average price of $316.42 and a 200-day moving average price of $442.28. The company has a market cap of $275.60 billion, a price-to-earnings ratio of 12.72, a price-to-earnings-growth ratio of 1.45 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the business earned $6.91 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on UNH shares. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Piper Sandler cut their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research report on Tuesday, June 3rd. Robert W. Baird downgraded shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a research note on Wednesday, June 11th. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $415.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.